Article

Curious Results in Myasthenia Gravis Study

An expert presents the results of a phase 2 study on the impact of rituximab on myasthenia gravis.

Dataemia value people over profits, quality over quantity, and keeping it real.
Entity Number: 10759945-0151 United States Holladay UT84121.
Back to top button